Latest Update: Impact of current COVID-19 situation has been considered in this report while making the analysis.
Global Oral Rotavirus Vaccine Market by Type (Rotarix, RotaTeq, Rotavac, Rotavin-M1, Lanzhou lamb), By Application (Hospital, Vaccination Station, Other) And By Region (North America, Latin America, Europe, Asia Pacific and Middle East & Africa), Forecast From 2022 To 2030-report

Global Oral Rotavirus Vaccine Market by Type (Rotarix, RotaTeq, Rotavac, Rotavin-M1, Lanzhou lamb), By Application (Hospital, Vaccination Station, Other) And By Region (North America, Latin America, Europe, Asia Pacific and Middle East & Africa), Forecast From 2022 To 2030

Report ID: 171004 3300 Pharma & Healthcare 377 240 Pages 5 (31)
                                          

Market Overview:


The global oral rotavirus vaccine market is expected to grow at a CAGR of XX% during the forecast period from 2018 to 2030. The growth in this market can be attributed to the increasing incidence of rotavirus infections, rising demand for pediatric vaccines, and growing investments by key players in research and development (R&D) activities. Based on type, the global oral rotavirus vaccine market can be segmented into Rotarix, RotaTeq, Rotavac, Rotavin-M1, and Lanzhou lamb. Of these types, Rotarix is expected to account for the largest share of the global oral rotavirus vaccine market during the forecast period. This can be attributed to its high efficacy and safety profile as well as its large product portfolio. Based on application, hospital accounted for the largest share of the global oral rotavirus vaccine market in 2017. This can be attributed to rising demand for pediatric vaccines from hospitals across regions owing to increasing awareness about their benefits among parents/guardians.


Global Oral Rotavirus Vaccine Industry Outlook


Product Definition:


An oral rotavirus vaccine is a vaccine that is given orally (by mouth). It protects against rotavirus, a virus that can cause severe diarrhea.


Rotarix:


Rotarix is a vaccine against rotavirus. It is developed by GlaxoSmithKline Biologicals and was approved in Europe in 2006 and 2007 for the prevention of gastro-intestinal diseases, including Rotarix-related diarrhea among children below five years of age. The vaccine has been licensed by GSK for use in more than 50 countries across the globe, with India being one of them.


RotaTeq:


RotaTeq is a non-adjuvanted oral vaccine against rotavirus. It is manufactured by Merck & Co., Inc. and was approved in 2015 for use in the U.S and 2016 for use across Europe, Australia, Latin America, and some Asian countries including Japan.


Application Insights:


Based on the application, the global oral rotavirus vaccine market is segmented into hospital, vaccination station, and others. Hospital was estimated as the largest application segment in 2017 owing to growing awareness about immunization against Rotarix, RotaTeq and other brands of oral vaccines. Growing number of hospitals with immunization stations for children under 5 years old also supported in major part towards larger share of this segment. Other applications include travel clinics and private practices.


Rising incidences associated with immunity against only one strain ofRotavirus has created a need for new vaccines that offer protection against different strains as well as a broader spectrum of infection which includes both G1 & G2 viruses globally since 2012 when RotaTeq was approved by U.


Regional Analysis:


Europe dominated the global market in 2017 owing to high demand for new rotavirus vaccines and presence of a large number of players. The European Commission has approved two rotavirus vaccine candidates, RotaTeq (Trumenba) and Rotarix (RVX-1473), for marketing. These factors are expected to boost the regional market during the forecast period.


Asia Pacific is anticipated to witness lucrative growth over the forecast period due to increasing awareness about vaccination programs among children, parents, and healthcare providers in this region. Furthermore, growing target population base along with rising incidence rate of severe diarrhea caused by rotavirus infection is also expected drive regional growth over the next eight years.


Growth Factors:


  • Increasing incidence of rotavirus infection in children across the globe
  • Rising demand for oral rotavirus vaccine due to its safety and efficacy
  • Growing awareness about the benefits of oral rotavirus vaccine among parents and healthcare professionals
  • Technological advancements in oral rotavirus vaccine manufacturing process
  • increasing government initiatives to promote vaccination against rotavirus infection

Scope Of The Report

Report Attributes

Report Details

Report Title

Oral Rotavirus Vaccine Market Research Report

By Type

Rotarix, RotaTeq, Rotavac, Rotavin-M1, Lanzhou lamb

By Application

Hospital, Vaccination Station, Other

By Companies

GSK, Sanofi-Pasteur, Merck, Biological E. Limited, China National Biotec Group, Sinovac Biotech

Regions Covered

North America, Europe, APAC, Latin America, MEA

Base Year

2021

Historical Year

2019 to 2020 (Data from 2010 can be provided as per availability)

Forecast Year

2030

Number of Pages

240

Number of Tables & Figures

168

Customization Available

Yes, the report can be customized as per your need.


Global Oral Rotavirus Vaccine Market Report Segments:

The global Oral Rotavirus Vaccine market is segmented on the basis of:

Types

Rotarix, RotaTeq, Rotavac, Rotavin-M1, Lanzhou lamb

The product segment provides information about the market share of each product and the respective CAGR during the forecast period. It lays out information about the product pricing parameters, trends, and profits that provides in-depth insights of the market. Furthermore, it discusses latest product developments & innovation in the market.

Applications

Hospital, Vaccination Station, Other

The application segment fragments various applications of the product and provides information on the market share and growth rate of each application segment. It discusses the potential future applications of the products and driving and restraining factors of each application segment.

Some of the companies that are profiled in this report are:

  1. GSK
  2. Sanofi-Pasteur
  3. Merck
  4. Biological E. Limited
  5. China National Biotec Group
  6. Sinovac Biotech

Global Oral Rotavirus Vaccine Market Overview


Highlights of The Oral Rotavirus Vaccine Market Report:

  1. The market structure and projections for the coming years.
  2. Drivers, restraints, opportunities, and current trends of market.
  3. Historical data and forecast.
  4. Estimations for the forecast period 2030.
  5. Developments and trends in the market.
  6. By Type:

    1. Rotarix
    2. RotaTeq
    3. Rotavac
    4. Rotavin-M1
    5. Lanzhou lamb
  1. By Application:

    1. Hospital
    2. Vaccination Station
    3. Other
  1. Market scenario by region, sub-region, and country.
  2. Market share of the market players, company profiles, product specifications, SWOT analysis, and competitive landscape.
  3. Analysis regarding upstream raw materials, downstream demand, and current market dynamics.
  4. Government Policies, Macro & Micro economic factors are also included in the report.

We have studied the Oral Rotavirus Vaccine Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2030.

Regional Analysis

  • North America
  • Europe
  • Asia Pacific
  • Middle East & Africa
  • Latin America

Note: A country of choice can be added in the report at no extra cost. If more than one country needs to be added, the research quote will vary accordingly.

The geographical analysis part of the report provides information about the product sales in terms of volume and revenue in regions. It lays out potential opportunities for the new entrants, emerging players, and major players in the region. The regional analysis is done after considering the socio-economic factors and government regulations of the countries in the regions.

How you may use our products:

  • Correctly Positioning New Products
  • Market Entry Strategies
  • Business Expansion Strategies
  • Consumer Insights
  • Understanding Competition Scenario
  • Product & Brand Management
  • Channel & Customer Management
  • Identifying Appropriate Advertising Appeals

Global Oral Rotavirus Vaccine Market Statistics

8 Reasons to Buy This Report

  1. Includes a Chapter on the Impact of COVID-19 Pandemic On the Market
  2. Report Prepared After Conducting Interviews with Industry Experts & Top Designates of the Companies in the Market
  3. Implemented Robust Methodology to Prepare the Report
  4. Includes Graphs, Statistics, Flowcharts, and Infographics to Save Time
  5. Industry Growth Insights Provides 24/5 Assistance Regarding the Doubts in the Report
  6. Provides Information About the Top-winning Strategies Implemented by Industry Players.
  7. In-depth Insights On the Market Drivers, Restraints, Opportunities, and Threats
  8. Customization of the Report Available

Frequently Asked Questions?


Oral rotavirus vaccine is a vaccine that helps protect against rotavirus, a virus that can cause severe diarrhea in infants and young children. Oral rotavirus vaccine is given as a shot to children aged 2 months through 6 years. It is also available as an oral drops for older children and adults.

Some of the key players operating in the oral rotavirus vaccine market are GSK, Sanofi-Pasteur, Merck, Biological E. Limited, China National Biotec Group, Sinovac Biotech.

                                            
1. Executive Summary

2. Assumptions and Acronyms Used

3. Research Methodology

4. Oral Rotavirus Vaccine Market Overview
   4.1. Introduction
      4.1.1. Market Taxonomy
      4.1.2. Market Definition
   4.2. Macro-Economic Factors
      4.2.1. Industry Outlook
   4.3. Oral Rotavirus Vaccine Market Dynamics
      4.3.1. Market Drivers
      4.3.2. Market Restraints
      4.3.3. Opportunity
      4.3.4. Market Trends
   4.4. Oral Rotavirus Vaccine Market - Supply Chain
   4.5. Global Oral Rotavirus Vaccine Market Forecast
      4.5.1. Oral Rotavirus Vaccine Market Size (US$ Mn) and Y-o-Y Growth
      4.5.2. Oral Rotavirus Vaccine Market Size (000’ Units) and Y-o-Y Growth
      4.5.3. Oral Rotavirus Vaccine Market Absolute $ Opportunity

5. Global Oral Rotavirus Vaccine Market Analysis and Forecast by Type
   5.1. Market Trends
   5.2. Introduction
      5.2.1. Basis Point Share (BPS) Analysis by Type
      5.2.2. Y-o-Y Growth Projections by Type
   5.3. Oral Rotavirus Vaccine Market Size and Volume Forecast by Type
      5.3.1. Rotarix
      5.3.2. RotaTeq
      5.3.3. Rotavac
      5.3.4. Rotavin-M1
      5.3.5. Lanzhou lamb
   5.4. Absolute $ Opportunity Assessment by Type
   5.5. Market Attractiveness/Growth Potential Analysis by Type

6. Global Oral Rotavirus Vaccine Market Analysis and Forecast by Application
   6.1. Market Trends
   6.2. Introduction
      6.2.1. Basis Point Share (BPS) Analysis by Application
      6.2.2. Y-o-Y Growth Projections by Application
   6.3. Oral Rotavirus Vaccine Market Size and Volume Forecast by Application
      6.3.1. Hospital
      6.3.2. Vaccination Station
      6.3.3. Other
   6.4. Absolute $ Opportunity Assessment by Application
   6.5. Market Attractiveness/Growth Potential Analysis by Application

7. Global Oral Rotavirus Vaccine Market Analysis and Forecast by Sales Channel
   7.1. Market Trends
   7.2. Introduction
      7.2.1. Basis Point Share (BPS) Analysis by Sales Channel 
      7.2.2. Y-o-Y Growth Projections by Sales Channel
   7.3. Oral Rotavirus Vaccine Market Size and Volume Forecast by Sales Channel 
      7.3.1. Manufacturer/Distributor/Service Provider
      7.3.2. Aftermarket
   7.4. Absolute $ Opportunity Assessment by Sales Channel
   7.5. Market Attractiveness/Growth Potential Analysis by Sales Channel

8. Global Oral Rotavirus Vaccine Market Analysis and Forecast by Region
   8.1. Market Trends
   8.2. Introduction
      8.2.1. Basis Point Share (BPS) Analysis by Region
      8.2.2. Y-o-Y Growth Projections by Region
   8.3. Oral Rotavirus Vaccine Market Size and Volume Forecast by Region
      8.3.1. North America
      8.3.2. Latin America
      8.3.3. Europe
      8.3.4. Asia Pacific
      8.3.5. Middle East and Africa (MEA)
   8.4. Absolute $ Opportunity Assessment by Region
   8.5. Market Attractiveness/Growth Potential Analysis by Region
   8.6. Global Oral Rotavirus Vaccine Demand Share Forecast, 2019-2026

9. North America Oral Rotavirus Vaccine Market Analysis and Forecast
   9.1. Introduction
      9.1.1. Basis Point Share (BPS) Analysis by Country
      9.1.2. Y-o-Y Growth Projections by Country
   9.2. North America Oral Rotavirus Vaccine Market Size and Volume Forecast by Country
      9.2.1. U.S.
      9.2.2. Canada
   9.3. Absolute $ Opportunity Assessment by Country
   9.4. North America Oral Rotavirus Vaccine Market Size and Volume Forecast by Application
      9.4.1. Hospital
      9.4.2. Vaccination Station
      9.4.3. Other
   9.5. Basis Point Share (BPS) Analysis by Application
   9.6. Y-o-Y Growth Projections by Application
   9.7. North America Oral Rotavirus Vaccine Market Size and Volume Forecast by Type
      9.7.1. Rotarix
      9.7.2. RotaTeq
      9.7.3. Rotavac
      9.7.4. Rotavin-M1
      9.7.5. Lanzhou lamb
   9.8. Basis Point Share (BPS) Analysis by Type
   9.9. Y-o-Y Growth Projections by Type
   9.10. Market Attractiveness/Growth Potential Analysis
      9.10.1. By Country
      9.10.2. By Product Type
      9.10.3. By Application
      9.10.4. By Sales Channel
   9.11. North America Oral Rotavirus Vaccine Demand Share Forecast, 2019-2026

10. Latin America Oral Rotavirus Vaccine Market Analysis and Forecast
   10.1. Introduction
      10.1.1. Basis Point Share (BPS) Analysis by Country
      10.1.2. Y-o-Y Growth Projections by Country
      10.1.3. Latin America Average Pricing Analysis
   10.2. Latin America Oral Rotavirus Vaccine Market Size and Volume Forecast by Country
      10.2.1. Brazil
      10.2.2. Mexico
      10.2.3. Rest of Latin America
   10.3. Absolute $ Opportunity Assessment by Country
   10.4. Latin America Oral Rotavirus Vaccine Market Size and Volume Forecast by Application
      10.4.1. Hospital
      10.4.2. Vaccination Station
      10.4.3. Other
   10.5. Basis Point Share (BPS) Analysis by Application
   10.6. Y-o-Y Growth Projections by Application
   10.7. Latin America Oral Rotavirus Vaccine Market Size and Volume Forecast by Type
      10.7.1. Rotarix
      10.7.2. RotaTeq
      10.7.3. Rotavac
      10.7.4. Rotavin-M1
      10.7.5. Lanzhou lamb
   10.8. Basis Point Share (BPS) Analysis by Type
   10.9. Y-o-Y Growth Projections by Type
   10.10. Market Attractiveness/Growth Potential Analysis
      10.10.1. By Country
      10.10.2. By Product Type
      10.10.3. By Application
      10.10.4. By Sales Channel
   10.11. Latin America Oral Rotavirus Vaccine Demand Share Forecast, 2019-2026

11. Europe Oral Rotavirus Vaccine Market Analysis and Forecast
   11.1. Introduction
      11.1.1. Basis Point Share (BPS) Analysis by Country
      11.1.2. Y-o-Y Growth Projections by Country
      11.1.3. Europe Average Pricing Analysis
   11.2. Europe Oral Rotavirus Vaccine Market Size and Volume Forecast by Country
      11.2.1. Germany
      11.2.2. France
      11.2.3. Italy
      11.2.4. U.K.
      11.2.5. Spain
      11.2.6. Russia
      11.2.7. Rest of Europe
   11.3. Absolute $ Opportunity Assessment by Country
   11.4. Europe Oral Rotavirus Vaccine Market Size and Volume Forecast by Application
      11.4.1. Hospital
      11.4.2. Vaccination Station
      11.4.3. Other
   11.5. Basis Point Share (BPS) Analysis by Application
   11.6. Y-o-Y Growth Projections by Application
   11.7. Europe Oral Rotavirus Vaccine Market Size and Volume Forecast by Type
      11.7.1. Rotarix
      11.7.2. RotaTeq
      11.7.3. Rotavac
      11.7.4. Rotavin-M1
      11.7.5. Lanzhou lamb
   11.8. Basis Point Share (BPS)Analysis by Type
   11.9. Y-o-Y Growth Projections by Type
   11.10. Market Attractiveness/Growth Potential Analysis
      11.10.1. By Country
      11.10.2. By Product Type
      11.10.3. By Application
      11.10.4. By Sales Channel
   11.11. Europe Oral Rotavirus Vaccine Demand Share, 2019-2026

12. Asia Pacific Oral Rotavirus Vaccine Market Analysis and Forecast
   12.1. Introduction
      12.1.1. Basis Point Share (BPS) Analysis by Country
      12.1.2. Y-o-Y Growth Projections by Country
      12.1.3. Asia Pacific Average Pricing Analysis
   12.2. Asia Pacific Oral Rotavirus Vaccine Market Size and Volume Forecast by Country
      12.2.1. China
      12.2.2. Japan
      12.2.3. South Korea
      12.2.4. India
      12.2.5. Australia
      12.2.6. Rest of Asia Pacific (APAC)
   12.3. Absolute $ Opportunity Assessment by Country
   12.4. Asia Pacific Oral Rotavirus Vaccine Market Size and Volume Forecast by Application
      12.4.1. Hospital
      12.4.2. Vaccination Station
      12.4.3. Other
   12.5. Basis Point Share (BPS) Analysis by Application
   12.6. Y-o-Y Growth Projections by Application
   12.7. Asia Pacific Oral Rotavirus Vaccine Market Size and Volume Forecast by Type
      12.7.1. Rotarix
      12.7.2. RotaTeq
      12.7.3. Rotavac
      12.7.4. Rotavin-M1
      12.7.5. Lanzhou lamb
   12.8. Basis Point Share (BPS) Analysis by Type
   12.9. Y-o-Y Growth Projections by Type
   12.10. Market Attractiveness/Growth Potential Analysis
      12.10.1. By Country
      12.10.2. By Product Type
      12.10.3. By Application
      12.10.4. By Sales Channel
   12.11. Asia Pacific Oral Rotavirus Vaccine Demand Share, 2019-2026

13. Middle East & Africa Oral Rotavirus Vaccine Market Analysis and Forecast
   13.1. Introduction
      13.1.1. Basis Point Share (BPS) Analysis by Country
      13.1.2. Y-o-Y Growth Projections by Country
      13.1.3. Asia Pacific Average Pricing Analysis
   13.2. Middle East & Africa Oral Rotavirus Vaccine Market Size and Volume Forecast by Country
      13.2.1. Saudi Arabia
      13.2.2. South Africa
      13.2.3. UAE
      13.2.4. Rest of Middle East & Africa (MEA)
   13.3. Absolute $ Opportunity Assessment by Country
   13.4. Middle East & Africa Oral Rotavirus Vaccine Market Size and Volume Forecast by Application
      13.4.1. Hospital
      13.4.2. Vaccination Station
      13.4.3. Other
   13.5. Basis Point Share (BPS) Analysis by Application
   13.6. Y-o-Y Growth Projections by Application
   13.7. Middle East & Africa Oral Rotavirus Vaccine Market Size and Volume Forecast by Type
      13.7.1. Rotarix
      13.7.2. RotaTeq
      13.7.3. Rotavac
      13.7.4. Rotavin-M1
      13.7.5. Lanzhou lamb
   13.8. Basis Point Share (BPS) Analysis by Type
   13.9. Y-o-Y Growth Projections by Type
   13.10. Market Attractiveness/Growth Potential Analysis
      13.10.1. By Country
      13.10.2. By Product Type
      13.10.3. By Application
      13.10.4. By Sales Channel
   13.11. Middle East & Africa Oral Rotavirus Vaccine Demand Share, 2019-2026

14. Competition Landscape
   14.1. Global Oral Rotavirus Vaccine Market: Market Share Analysis
   14.2. Oral Rotavirus Vaccine Distributors and Customers
   14.3. Oral Rotavirus Vaccine Market: Competitive Dashboard
   14.4. Company Profiles (Details – Overview, Financials, Developments, Strategy) 
      14.4.1. GSK
         14.4.1.1. Overview
         14.4.1.2. Financials
         14.4.1.3. Developments
         14.4.1.4. Strategic Outlook
      14.4.2. Sanofi-Pasteur
         14.4.2.1. Overview
         14.4.2.2. Financials
         14.4.2.3. Developments
         14.4.2.4. Strategic Outlook
      14.4.3. Merck
         14.4.3.1. Overview
         14.4.3.2. Financials
         14.4.3.3. Developments
         14.4.3.4. Strategic Outlook
      14.4.4. Biological E. Limited
         14.4.4.1. Overview
         14.4.4.2. Financials
         14.4.4.3. Developments
         14.4.4.4. Strategic Outlook
      14.4.5. China National Biotec Group
         14.4.5.1. Overview
         14.4.5.2. Financials
         14.4.5.3. Developments
         14.4.5.4. Strategic Outlook
      14.4.6. Sinovac Biotech
         14.4.6.1. Overview
         14.4.6.2. Financials
         14.4.6.3. Developments
         14.4.6.4. Strategic Outlook
      14.4.7. COMPANY7
         14.4.7.1. Overview
         14.4.7.2. Financials
         14.4.7.3. Developments
         14.4.7.4. Strategic Outlook
      14.4.8. COMPANY8
         14.4.8.1. Overview
         14.4.8.2. Financials
         14.4.8.3. Developments
         14.4.8.4. Strategic Outlook
      14.4.9. COMPANY9
         14.4.9.1. Overview
         14.4.9.2. Financials
         14.4.9.3. Developments
         14.4.9.4. Strategic Outlook
      14.4.10. COMPANY 10
         14.4.10.1. Overview
         14.4.10.2. Financials
         14.4.10.3. Developments
         14.4.10.4. Strategic Outlook
      14.4.11. COMPANY 11
         14.4.11.1. Overview
         14.4.11.2. Financials
         14.4.11.3. Developments
         14.4.11.4. Strategic Outlook
      14.4.12. COMPANY 12
         14.4.12.1. Overview
         14.4.12.2. Financials
         14.4.12.3. Developments
         14.4.12.4. Strategic Outlook
      14.4.13. COMPANY 13
         14.4.13.1. Overview
         14.4.13.2. Financials
         14.4.13.3. Developments
         14.4.13.4. Strategic Outlook
      14.4.14. COMPANY 14
         14.4.14.1. Overview
         14.4.14.2. Financials
         14.4.14.3. Developments
         14.4.14.4. Strategic Outlook
      14.4.15. COMPANY 15
         14.4.15.1. Overview
         14.4.15.2. Financials
         14.4.15.3. Developments
         14.4.15.4. Strategic Outlook
      14.4.16. COMPANY 16
         14.4.16.1. Overview
         14.4.16.2. Financials
         14.4.16.3. Developments
         14.4.16.4. Strategic Outlook
      14.4.17. COMPANY 17
         14.4.17.1. Overview
         14.4.17.2. Financials
         14.4.17.3. Developments
         14.4.17.4. Strategic Outlook
      14.4.18. COMPANY 18
         14.4.18.1. Overview
         14.4.18.2. Financials
         14.4.18.3. Developments
         14.4.18.4. Strategic Outlook
      14.4.19. COMPANY 19
         14.4.19.1. Overview
         14.4.19.2. Financials
         14.4.19.3. Developments
         14.4.19.4. Strategic Outlook
      14.4.20. COMPANY 20
         14.4.20.1. Overview
         14.4.20.2. Financials
         14.4.20.3. Developments
         14.4.20.4. Strategic Outlook

Our Trusted Clients

Contact Us